Bixin

Bixin

SCHEMBL22344763

CCOCC.COC(=O)/C=C/C(C)=C/C=C/C(C)=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C(=O)O

nearest known ligand 0.82

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.82
▸ TDP1 Q9NUW8 2/20 0.82
▸ MAPT P10636 2/20 0.82
▸ KDM4E B2RXH2 1/20 0.82
▸ ALOX15 P16050 2/20 0.73
▸ RECQL P46063 2/20 0.73
▸ HSD17B10 Q99714 2/20 0.73
▸ TSHR P16473 1/20 0.61
▸ HCAR2 Q8TDS4 8/20 0.52
▸ PTGS1 P23219 2/20 0.42
▸ PTPN1 P18031 1/20 0.40
▸ KEAP1 Q14145 1/20 0.39
▸ NFE2L2 Q16236 1/20 0.39
▸ NR1I2 O75469 2/20 0.32
▸ ABCC4 O15439 1/20 0.32
▸ ABCB11 O95342 1/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.32
▸ GFPT1 Q06210 1/20 0.32
▸ PGR P06401 2/20 0.32
▸ LMNA P02545 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bixin SCHEMBL29959685 0.91 ALDH1A1 (1.00) ALDH1A1TDP1MAPTKDM4EALOX15
Bixin SCHEMBL42729 0.91 ALDH1A1 (1.00) ALDH1A1TDP1MAPTKDM4EALOX15
Bixin SCHEMBL9939959 0.91 ALDH1A1 (1.00) ALDH1A1TDP1MAPTKDM4EALOX15
Bixin SCHEMBL29939591 0.91 ALDH1A1 (1.00) ALDH1A1TDP1MAPTKDM4EALOX15
SCHEMBL1463087 0.85 ALDH1A1 (1.00) ALDH1A1TDP1MAPTKDM4EALOX15
SCHEMBL30873767 0.85 ALDH1A1 (1.00) ALDH1A1TDP1MAPTKDM4EALOX15
Monomethyl Fumarate SCHEMBL7848423 0.83 HCAR2 (0.74) ALDH1A1TDP1MAPTKDM4EALOX15
SCHEMBL30404058 0.83 ALDH1A1 (0.85) ALDH1A1TDP1MAPTKDM4EALOX15
Bixin SCHEMBL3287610 0.82 ALDH1A1 (0.82) ALDH1A1TDP1MAPTKDM4EALOX15
SCHEMBL25460630 0.79 ALDH1A1 (0.77) ALDH1A1TDP1MAPTKDM4EALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10800735-B2 Intermediate compound for manufacturing bixin ethyl ester and method of manufacturing the same MYONGJI UNIVERSITY INDUSTRY AND ACADEMIA COOPERATION FOUNDATION (KR) 2020-10-13 — — US disclosed
US-20200262786-A1 NOVEL INTERMEDIATE COMPOUND FOR MANUFACTURING BIXIN ETHYL ESTER AND METHOD OF MANUFACTURING THE SAME MYONGI UNIVERSITY INDUSTRY AND ACADEMIA COOPERATION FOUNDATION (KR) 2020-08-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200262786-A1 NOVEL INTERMEDIATE COMPOUND FOR MANUFACTURING BIXIN ETHYL ESTER AND METHOD OF MANUFACTURING THE SAME BRIX1, CYP4X1, BROX ALDH1A1 2616/4885TDP1 3708/4885MAPT 3415/4885
US-10800735-B2 Intermediate compound for manufacturing bixin ethyl ester and method of manufacturing the same BRIX1, BROX, CYP4X1 ALDH1A1 2686/4885TDP1 3782/4885MAPT 3505/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback